IMAGINDAIRY - Key Persons
Over 30 years of experience in biotechnology with deep knowledge of protein biochemistry, immunology, molecular signaling, cell biology, and regenerative medicine. Prior to founding Imagindairy, Arie led and managed R&D in a diverse therapeutic areas and successfully developed novel therapeutics at Onyx Pharmaceutical, Nuvelo and California Institute of Regenerative Medicine. Arie holds a Ph.D. in Microbiology from Tel Aviv University and a Bsc in Biochemistry from the University of California, Los Angeles (UCLA).
With extensive experience in executive roles for biotechnology companies like Enzymotec and Algatechnologies, Eyal brings his wide-ranging education to the forefront leading the helm at Imagindairy. His specialities in nano-scale drug delivery systems development and scale-up management skills are supported by his Ph.D in Pharmaceutics from the Hebrew University of Jerusalem and a BSc in Biochemical Engineering from Technion- Israel Institute of Technology.
Greg combines his prior experiences as Operations Project Manager (Enzymotec) and Head of Process & Development (Solabia-Algatech Nutrition) to lead operations at Imagindairy. He has helped companies grow their products from the lab to reach commercial scale and led interdisciplinary teams to execute production plans, while adhering to compliance and regulations. With an MBA from COLMAN College of Management and BSc in Biotechnology from Braude College of Engineering, Greg helps to transform novel ideas into feasible solutions.
With over 15 years of managerial experience, Lilach brings people together through successful talent acquisition, management, organizational development, and her extensive skill set and understanding of talent needs to help reach business goals. Her education spans an MBA from Peres Academic Center, following her culmination earning a BA in Behavioral Science from Ben-Gurion University of the Negev.
With over 15 years of experience in finance, M&A, and operations management, Omer couples long-term planning with his practical vision to drive a culture of innovation in his role as CFO. As both a CPA and attorney, Omer formerly served as the CFO of Binah.ai, CFO and COO for RadView Software Ltd., and worked at EY, where he managed private and public company accounts. He holds an MBA from Tel Aviv University, a B.A. (magna cum laude) in Business Administration and an LL.B. (magna cum laude) from The College of Management.
With a proven background in leading marketing and business development for biotech and medical startups, Roni brings an interdisciplinary perspective as Vice President of Business Development. She has successfully led strategic innovation processes, grown global partnerships, and managed customer relations for reputable companies like Ernst & Young, Enzymotec, and others. Roni holds a BSc (summa cum laude) in Biotechnology Engineering and an MSc in Medical Sciences, both from the Technion- Israel Institute of Technology, as well as an MBA (cum laude) from the Open University of Israel.
Job Titles:
- Co - Founder & CAIO
- Professor
In addition to his role as Co-founder and CAIO, Tuller also serves as a full-time professor with tenure at Tel Aviv University, where he leads the Computational Systems and Synthetic Biology laboratory (one of the largest labs in Israel).
Throughout his noteworthy career, he has been awarded many prestigious prizes and fellowships, and has authored over 150 peer reviewed scientific journal articles. He holds four BScs, two Mscs, and two PhDs spanning electrical engineering, mechanical engineering, computer science, medicine and biology most of them from Tel Aviv University.
Tomer brings his robust pharmaceutical experience as part of companies like Dexcel Ltd, Cynapsus Therapeutics, and Teva Pharmaceutical Industries Ltd. to drive Imagindairy forward by leading R&D operations, budgeting, planning, and regulatory development activities. Prior to this role, he was responsible for interacting with global regulatory agencies, developing and launching new drug products, and executing clinical trials. Backed by a Msc in Biomedical Engineering and Bsc in Chemical Engineering from Technion-Israel Institute of Technology, Tomer bridges the gap between science and business with his superior management and leadership skills.